Flavonoids have been showing diversified bioactivities. Primary amoebic meningoencephalitis is a brain inflammation caused by Naegleria fowleri brain eating amoeba. In this manuscript, we selected 93 flavonoids by extensive literature survey and 83 flavonoids passed drug likeness parameter. Selected flavonoids were molecular docked against primary amoebic meningoencephalitis Naegleria fowleri CYP51 receptor considering voriconazole as standard. Beta naphthoflavone, abyssinone I, abyssinone III showed maximum docking scores of ‐10.9 kcal/mol, ‐10.7 kcal/mol, and ‐10.6 kcal/mol, respectively whereas voriconazole showed docking scores of ‐7.6 kcal/mol. MD simulation data showed that RMSD values attained almost a static value during the simulation and all nearest interacting amino acid residues were fluctuated within limit. MMPBSA data of beta naphthoflavone abyssinone I, abyssinone III, and voriconazole showed free binding energies of ‐82.755 kJ/mol, ‐1924.193 kJ/mol, ‐1890.335 kJ/mol, and ‐540.141 kJ/mol, respectively. FMO analysis showed abyssinone III was the chemically reactive molecule and beta naphthoflavone showed maximum electrophilicity. MEP analysis portrayed possible nucleophilic‐electrophilic attack areas of the structures. PCA and FEL analysis data confirmed the stable conformations between flavonoids and receptor. Abyssinone I and III showed non toxic behavior. These data confirmed that if we repurpose these flavonoids against primary amoebic meningoencephalitis, it will be beneficial for mankind.